Worldwide: Food and Drugs Law

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

California SB 41: Pharmacy Benefit Managers Now Held To Fiduciary And Transparency Standards

California establishes fiduciary duties and transparency mandates for PBMs, reshaping the PBM contracting landscape with health plans beginning in 2026

United States Employment

DW

Davis Wright Tremaine

CRLs Unveiled: Converting FDA Transparency Into A Market Advantage

With the FDA's disclosure of 200 Complete Response Letters (CRLs), leadership teams now have an unprecedented insight into regulatory decision-making to glean patterns...

United States Healthcare

AM

Alvarez & Marsal

U.S. Sanctions Colombia's President Under Global Illicit Drug Trade Program

The U.S. Department of the Treasury's Office of Foreign Assets Control (OFAC) has designated Colombia's sitting president, Gustavo Francisco Petro Urrego, under Executive Order 14059, which imposes sanctions on foreign persons involved in the global illicit drug trade.

United States International

HK

Holland & Knight

New Drug Approvals: "Human Organ-on-a-Chip" GAO Report Supports Innovation And Regulatory Policy For Non-Animal Models

Animal models remain foundational to biomedical research, having contributed to the development of vaccines, drugs, and surgical innovations. But their continued use faces growing scrutiny due to ethical concerns...

United States Healthcare

FL

Foley & Lardner

Holland & Knight Health Dose: October 28, 2025

United States Healthcare

HK

Holland & Knight

Illinois To Require Illinois-Licensed PICs For Nonresident Pharmacies Effective January 1, 2026

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Open Season Nears: Advanced Premium Tax Credits And Potential Paths Forward

United States Healthcare

HK

Holland & Knight

FDA Presses Forward On Patient-Focused Drug Development, Releases Final Guidance Focused On Fit-For-Purpose Clinical Outcome Assessments

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

This Week From The Hill (October 26 – November 1, 2025)

United States Employment

GL

Groom Law Group

Trump Administration Targets PBM Reform To Lower Drug Prices

United States Healthcare

HB

Hall Benefits Law

AI In Health Care And Biotechnology: Promise, Progress, And Challenges

United States Healthcare

FL

Foley & Lardner

California's Governor Newsom Announces That State Sponsored Insulin Pen Will Be Available Jan 1, 2026

United States Healthcare

GP

Goodwin Procter LLP

Recent Rulings Highlight Risk To Japanese Drugmakers In Settling Pharmaceutical Litigations

United States Healthcare

JB

Jenner & Block

The Alabama Board Of Pharmacy: What Licensees Need To Know About Rule 680-X-2-.40 Ahead Of The November 19 Hearing/Meeting

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

The Changes To The English Arbitration Regime: What Parties To International Construction Disputes Need To Know

United States Litigation

J

JAMS

[PODCAST] Utilizing Co-Mediation - Bringing Together Multiple Perspectives To Reach Effective Settlements

United States Litigation

J

JAMS

USCIS Announces Changes To The Naturalization Test

United States Immigration

Gs

Green and Spiegel

Greenwashing Legislation Trends: Key Takeaways For Businesses

Worldwide Commercial

RG

Ropes & Gray LLP

AMTL's AICP Files Second Case Against TSMC, Its Advanced Memory Amends Against SK Hynix

United States IP

RC

RPX Corporation

Food Venture Financing News – Weekly Issue No. 258

Starship, a robotic food delivery company, announced that it raised $50 million in its Series C financing round.

United States Healthcare

DW

Davis Wright Tremaine

Navigating TTB And FDA Regulations To Advance Sustainable Wine Production

Wine producers face increasing pressure to deliver quality wine with distinctive character while simultaneously reducing environmental impact.

United States Healthcare

SJ

Steptoe LLP

FDA Regulatory Approval Updates

On October 17, 2025, Amgen and AstraZeneca announced that the FDA has approved an additional indication for TEZSPIRE (tezepelumab-ekko) for the add-on maintenance treatment of inadequately controlled...

United States Healthcare

GP

Goodwin Procter LLP

California's AB 1264 Introduces The First Legal Definition Of Ultra-Processed Food

On October 8, 2025, Governor Gavin Newson signed into law Assembly Bill 1264, the Real Food, Healthy Kids Act, as an attempt to phase out...

United States Healthcare

FL

Foley & Lardner

California's Governor Signs New Pharmacy Benefit Manager Law Into Effect

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

AG Event Insider: 2025 NAAG Consumer Protection Fall Conference

United States Finance

CO

Cozen O'Connor

FDA Names The First Nine National Priority Voucher Recipients

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

The Next Phase Of Vertical Integration: Wholesalers Join The Game

United States Healthcare

JW

Jones Walker

Replay: Wearables Webinar Series, Part 1: Update On FDA Regulation On Wearables (Video)

United States Healthcare

DM

Duane Morris LLP

Texas Chili: History, The Bean Debate, And The Law Behind The Legend

United States Healthcare

K

Klemchuk

New California Law Establishes Extensive Rules For Pharmacy Benefit Manager Conduct

United States Healthcare

DM

Duane Morris LLP

Pivot Point For 340B: HRSA Rebate Model Pilot Program Approaches Launch

United States Healthcare

CM

Crowell & Moring LLP

FDA Announces Inaugural Products To Receive Commissioner's National Priority Vouchers

United States Healthcare

HK

Holland & Knight

Inside The FDA: Insights From Former Regulators

United States Healthcare

WL

WIT Legal

New California Law Establishes Extensive Rules For Pharmacy Benefit Manager Conduct

On October 11, 2025, California Governor Gavin Newsom approved Senate Bill No. 41, a law that creates extensive restrictions on the business operations, pricing models and other aspects of pharmacy benefits managers (PBMs) in California.

United States Healthcare

DM

Duane Morris LLP

Pivot Point For 340B: HRSA Rebate Model Pilot Program Approaches Launch

The deadline for Department of Health and Human Services ("HHS") to notify approved manufacturers of acceptance into the 340B Rebate Model Pilot Program has passed...

United States Healthcare

CM

Crowell & Moring LLP

FDA Announces Inaugural Products To Receive Commissioner's National Priority Vouchers

The U.S. Food and Drug Administration (FDA) announced on Oct. 16, 2025, that it would award the first-ever Commissioner's National Priority Vouchers (CNPV) to nine recipients across various disease states and conditions.

United States Healthcare

HK

Holland & Knight

Inside The FDA: Insights From Former Regulators

What forces are shaping today's regulatory environment? In this latest Q&A, we asked our Former FDA Expert Team to weigh in on some of the most pressing questions...

United States Healthcare

WL

WIT Legal

Transportation Department Proposes Adding Fentanyl To Drug Testing Panel

United States Healthcare

JL

Jackson Lewis P.C.

Understanding California SB-41: What PBMs Operating In California Need To Know

On October 11, 2025, California Governor Gavin Newsom signed Senate Bill 41 (SB-41) into law, introducing a comprehensive set of new regulations for pharmacy benefit managers (PBMs) operating in the state.

United States Healthcare

M

Mintz

Employers Anticipate 10% Increase In 2026 Healthcare Costs

According to data from the International Foundation of Employee Benefit Plans (IFEBP), which has 31,000 member employers...

United States Employment

HB

Hall Benefits Law

Part II: Recent Changes In Jury Dynamics And How To Prepare Your Expert Accordingly (Podcast)

In the second part of this special guest episode of "The Trial Lawyer's Handbook" podcast series, litigation attorney Dan Small is once again joined by Partner Eric Alexander...

United States Consumer

HK

Holland & Knight

What To Watch: Human Cell And Tissue Product Regulation

Since the year began, we have attempted to divine the new administration's approach to regulating human cell and tissue products ("HCT/Ps").

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

Assessing The Impact Of The Long-Stay Antipsychotic Measure On Access To Patient-Centered Care

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

Food Venture Financing News – Weekly Issue No. 257

United States Healthcare

DW

Davis Wright Tremaine

FDA In Flux – October 2025 Newsletter

United States Healthcare

M

Mintz

AstraZeneca Announces New Most-Favored-Nation Pricing Initiatives

United States Healthcare

MP

Manatt, Phelps & Phillips LLP

Conception & Inventorship Under Pharmaceutical Patent Law: Lessons And Best Practices

United States IP

UT

Upadhye Tang

Environmental Developments To Watch In New England

United States Environment

BD

Beveridge & Diamond

Recent Federal Developments For October 2025

United States Environment

BC

Bergeson & Campbell

The PBM Effect: Regulatory And Market Implications For Life Sciences Companies And Healthcare Providers

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Update On Texas Executive Order GA-56

United States Cannabis

BI

Buchanan Ingersoll & Rooney PC

Update: Status Of FTC Case Against Three Largest PBMs

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

FDA Approves Celltrion's Aflibercept Biosimilar

United States Healthcare

GP

Goodwin Procter LLP

Colorado Limits Medicaid Coverage Of Definitive Drug Testing

United States Healthcare

PL

Polsinelli LLP

Ohio's PBM Regulation Passed By House Of Representatives

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

Benesch Healthcare+ Dialysis & Nephrology Digest No. 69

United States Healthcare

B

Benesch Friedlander Coplan & Aronoff LLP

Navigating Food And Dietary Supplements Labeling Litigation & Regulatory Hurdles In 2025 And Beyond (Video)

United States Healthcare

SM

Sheppard Mullin Richter & Hampton

See more

Highlighted Content

The Nexus Of Trade And Food Security Amid Global Conflicts

United States International

BG

Braumiller Law Group, PLLC

Any Comments On FDA's New Proposed Rule On Prior Notice Regulations?

United States International

BG

Braumiller Law Group, PLLC

World Trade And Invasion, One Year Later – Are We On The Brink Of A New World Order?

United States International

BG

Braumiller Law Group, PLLC

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

Latest Videos

See more

The Exploration Crisis: Why Oil & Gas Companies Are Finding Less While Demand Keeps Growing (Video)

AM

Alvarez & Marsal

Non-binding Guidance: The Administration's Focus On Direct-to-Consumer Prescription Drug Advertising (Podcast)

RG

Ropes & Gray LLP

Live From Workplace Horizons 2025: What's Hot In ERISA — Forfeiture And Tobacco Surcharge Class Actions (Video)

JL

Jackson Lewis P.C.

Concerns For Employers Surrounding Employee Drug And Alcohol Testing Policies (Video)

FS

Foster Swift Collins & Smith

Food And Consumer Product Litigation And Regulatory Update: Webinar Replay (Video)

ML

McGuireWoods LLP

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More